A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

Researchers at Oregon Health and Science University (OHSU) have made a big discovery. A new blood test is showing promising ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...

OHSU researchers discovered a new blood test that identifies pancreatic cancer early on with 85% accuracy when done alongside the current CA 19-9 test.

The parties, under the Agreement, plan to develop this blood-based test for potential ... the most robust and accurate screening test for pancreatic cancer on the market. “Securing the exclusive ...

PDAC, an aggressive and often difficult-to-diagnose cancer, frequently spreads before detection. The study, published in the ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), a molecular genetics diagnostic company specializing in early cancer detection ... detection of pancreatic cancer through a blood test.

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer Discovery Analysis Demonstrates Transformative Sensitivity of 95% ...